EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Determination of Gliclazide and Montelukast in Rat Plasma by a Validated RP‐HPLC Method and Its Application to a Pharmacokinetic Interaction Study

Israt Jahan Binta Elias, Md. Mofazzel Hossain, Md. Mamun Uddin, Shammi Shefa Un Nur Nishat, Mahmuda Ferdous, Prodip Kumar Baral, Md. Saddam Hussain, Rita Bhatta, Abhijit Das

SEPARATION SCIENCE PLUS · 2026-03 · 9 (3)

DOI: 10.1002/sscp.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift SEPARATION SCIENCE PLUS, online erschienen am 12.03.2026. Verfasst von Israt Jahan Binta Elias und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliclazide (antidiabetic) and montelukast (leukotriene antagonist) are frequently co‐prescribed in patients with Type 2 diabetes and coexisting asthma or allergy. However, no analytical approach has been documented for their simultaneous quantification in plasma using a simple, inexpensive RP‐HPLC‐UV assay, nor has their pharmacokinetic interaction been studied in vivo. This study developed and validated a new, rapid, and low‐volume RP‐HPLC for concurrent estimation of gliclazide and montelukast in rat plasma. Chromatographic separation was performed on a C 18 column utilizing isocratic elution with a 20 mM ammonium acetate buffer (pH 5.5) and acetonitrile in a 20:80 (v/v) ratio, at a flow rate of 1.0 mL/min, with a UV detector set at 228 nm. The method was validated in accordance with ICH M10 guidelines, encompassing selectivity, linearity, precision, accuracy, recovery, and matrix effect. The technique was utilized to characterize the pharmacokinetics of gliclazide, with and without montelukast, in male Sprague–Dawley rats. Gliclazide and montelukast eluted at 3.04 and 5.87 min, respectively, with resolution > 2 and tailing factors < 1.6. The method was linear over 5–10 000 ng/mL in plasma, with LOQs of 2.33 ng/mL (gliclazide) and 4.06 ng/mL (montelukast). Recovery exceeded 85%, and no significant matrix effects were observed. All stability conditions met the acceptance criteria. Co‐administration of montelukast significantly increased gliclazide exposure: C max increased by 116% and AUC 0–∞ by 180%, accompanied by prolonged t 1/2 and MRT and reduced elimination rate constant ( K el ), indicating a pharmacokinetic interaction. This study introduces the newly validated RP‐HPLC‐UV method for the concurrent determination of gliclazide and montelukast in plasma, offering the first in vivo evidence of a notable pharmacokinetic interaction between these two medications. This method is efficient, reliable, cost‐effective, and utilizes only 20 µL of plasma, rendering it exceptionally appropriate for routine preclinical drug–drug interaction investigations.

Zitieren

APA

Elias, I. J. B., Hossain, M. M., Uddin, M. M., Nishat, S. S. U. N., Ferdous, M., Baral, P. K., Hussain, M. S., Bhatta, R., & Das, A. (2026). Simultaneous Determination of Gliclazide and Montelukast in Rat Plasma by a Validated RP‐HPLC Method and Its Application to a Pharmacokinetic Interaction Study. SEPARATION SCIENCE PLUS, 9(3). https://doi.org/10.1002/sscp.70212

Vancouver

Elias IJB, Hossain MM, Uddin MM, Nishat SSUN, Ferdous M, Baral PK, et al. Simultaneous Determination of Gliclazide and Montelukast in Rat Plasma by a Validated RP‐HPLC Method and Its Application to a Pharmacokinetic Interaction Study. SEPARATION SCIENCE PLUS. 2026;9(3). doi:10.1002/sscp.70212

BibTeX
@article{Elias2026,
  author = {Elias, Israt Jahan Binta and Hossain, Md. Mofazzel and Uddin, Md. Mamun and Nishat, Shammi Shefa Un Nur and Ferdous, Mahmuda and Baral, Prodip Kumar and Hussain, Md. Saddam and Bhatta, Rita and Das, Abhijit},
  title = {Simultaneous Determination of Gliclazide and Montelukast in Rat Plasma by a Validated RP‐HPLC Method and Its Application to a Pharmacokinetic Interaction Study},
  journal = {SEPARATION SCIENCE PLUS},
  year = {2026},
  volume = {9},
  number = {3},
  doi = {10.1002/sscp.70212}
}
Kostenlos starten →